Back to KL KING LUTHER CAPITAL MANAGEMENT CORP

LGNDLGND
9 quarters

Position history for KLKING LUTHER CAPITAL MANAGEMENT CORP's holdings in LIGAND PHARMACEUTICALS INC

KING LUTHER CAPITAL MANAGEMENT CORP previously held 0 shares of LGND (LIGAND PHARMACEUTICALS INC), worth $0 as of 2020-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$2.7M

Total Shares Change

-19,765

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2020-Q4
Latest
Exited
0
-100.0%
$00.0%$64.02
0
2020-Q3
Decreased
27,550
-2.5%
$2.6M0.0%$59.76
0
2020-Q2
Decreased
28,245
-4.7%
$3.2M0.0%$70.51
0
2020-Q1
Decreased
29,630
-8.7%
$2.2M0.0%$44.42
0
2019-Q4
Increased
32,460
+84.6%
$3.4M0.0%$64.87
41
2019-Q3
Decreased
17,585
-32.4%
$1.8M0.0%$61.73
0
2019-Q2
Decreased
26,030
-1.0%
$3M0.0%$71.21
0
2019-Q1
Increased
26,295
+33.0%
$3.3M0.0%$78.42
34
2018-Q4
New
19,765
-
$2.7M0.0%$84.74
36

Other major holders of LGND: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used